Tuesday, July 28, 2020
A world-leading University of À¶Ý®ÊÓƵ spinoff company, that decodes blood samples for potential treatments for illnesses like cancer and COVID-19, is expanding operations with the help of a $5-million USD investment.
, a University of À¶Ý®ÊÓƵ computer science professor who cofounded  in 2015, says the company’s technology is the most advanced in the world when it comes to deciphering the complex workings of antibody proteins, a process called sequencing.
Learn more about the work of Ma and Rapid Novor.